Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study.: Predictors of declines in LDL-cholesterol

Kim Bouillon 1, 2, * Archana Singh-Manoux 1, 2, 3 Markus Jokela 1, 4 Martin Shipley 1 David Batty 1 Eric Brunner 1 Séverine Sabia 2 Adam Tabák 1, 5 Tasnime Akbaraly 1, 6 Jane Ferrie 1 Mika Kivimäki 1, 7
* Auteur correspondant
1 Department of Epidemiology and Public Health
2 CESP - Centre de recherche en épidémiologie et santé des populations
3 Centre de Gérontologie
4 Department of Psychology
5 1st Department of Medicine
6 Pathologies du système nerveux : recherche épidémiologique et clinique
7 Finnish Institute of Occupational Health
Abstract : OBJECTIVE: To examine the association of lipid-lowering drugs, change in diet and physical activity with a decline in low-density lipoprotein (LDL) cholesterol in middle age. DESIGN: A prospective cohort study. SETTING: The Whitehall II study. PARTICIPANTS: 4469 British civil servants (72% men) aged 39-62 years at baseline. MAIN OUTCOME MEASURE: Change in LDL-cholesterol concentrations between the baseline (1991-3) and follow-up (2003-4). RESULTS: Mean LDL-cholesterol decreased from 4.38 to 3.52 mmol/l over a mean follow-up of 11.3 years. In a mutually adjusted model, a decline in LDL-cholesterol was greater among those who were taking lipid-lowering treatment at baseline (-1.14 mmol/l, n=34), or started treatment during the follow-up (-1.77 mmol/l, n=481) compared with untreated individuals (n=3954; p<0.001); among those who improved their diet--especially the ratio of white to red meat consumption and the ratio of polyunsaturated to saturated fatty acids intake--(-0.07 mmol/l, n=717) compared with those with no change in diet (n=3071; p=0.03) and among those who increased physical activity (-0.10 mmol/l, n=601) compared with those with no change in physical activity (n=3312; p=0.005). Based on these estimates, successful implementation of lipid-lowering drug treatment for high-risk participants (n=858) and favourable changes in diet (n=3457) and physical activity (n=2190) among those with non-optimal lifestyles would reduce LDL-cholesterol by 0.90 to 1.07 mmol/l in the total cohort. CONCLUSIONS: Both lipid-lowering pharmacotherapy and favourable changes in lifestyle independently reduced LDL-cholesterol levels in a cohort of middle-aged men and women, supporting the use of multifaceted intervention strategies for prevention.
Keywords : cohort study LDL-cholesterol lipid lowering drug diet physical activity
Type de document :
Article dans une revue
British heart journal, BMJ Publishing Group, 2011, 97 (11), pp.923-30. 〈10.1136/hrt.2010.216309〉
Liste complète des métadonnées

Littérature citée [24 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00588857
Contributeur : Annie Schmaus <>
Soumis le : mercredi 26 octobre 2011 - 07:00:07
Dernière modification le : lundi 15 octobre 2018 - 10:46:02
Document(s) archivé(s) le : vendredi 27 janvier 2012 - 02:21:51

Fichiers

Bouillon_et_al._Heart_2011.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

CESP | U1061 | UVSQ

Citation

Kim Bouillon, Archana Singh-Manoux, Markus Jokela, Martin Shipley, David Batty, et al.. Decline in low-density lipoprotein cholesterol concentration: lipid-lowering drugs, diet, or physical activity? Evidence from the Whitehall II study.: Predictors of declines in LDL-cholesterol. British heart journal, BMJ Publishing Group, 2011, 97 (11), pp.923-30. 〈10.1136/hrt.2010.216309〉. 〈inserm-00588857〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

346

Téléchargements de fichiers

217

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD